Sebastian Rissom

Title: The Innovations of Sebastian Rissom

Introduction

Sebastian Rissom is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of biochemistry, particularly in steroid hydroxylation and polypeptide variants. With a total of 7 patents to his name, Rissom's work has implications in both medical and food industries.

Latest Patents

One of Rissom's latest patents focuses on the 21-hydroxylation of steroids. This invention relates to a method for the 21-hydroxylation of steroids in cells, involving cells that express a steroid 21-hydroxylating enzyme. It also includes expression vectors that comprise a nucleic acid encoding for a steroid 21-hydroxylase and a kit for carrying out the method. Another significant patent involves variants of porcine trypsin. This invention covers polypeptide variants of porcine trypsin, nucleic acid molecules encoding these variants, and host cells that contain such nucleic acids. The variants have potential uses in producing insulin, as well as applications as medicaments and food or feed ingredients.

Career Highlights

Throughout his career, Rissom has worked with prominent companies such as Sanofi and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in biochemistry.

Collaborations

Rissom has collaborated with notable colleagues, including Thomas Stillger and Claus Lattemann. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Sebastian Rissom's contributions to the field of biochemistry through his patents demonstrate his innovative spirit and dedication to advancing science. His work continues to impact various industries, showcasing the importance of research and collaboration in driving innovation.